Literature DB >> 15227539

NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin.

Lee-Jon Ball1, Catherine M Goult, James A Donarski, Jason Micklefield, Vasudevan Ramesh.   

Abstract

Daptomycin is an acidic lipopeptide antibiotic, whose three-dimensional structure and mechanism of action is currently unknown. Recently daptomycin, trade name Cubicin, was approved as a drug for the treatment of skin-related infections (M. Larkin Lancet, 2003, 3, 677) and became the first antibiotic of its class to be used in the clinic (A. Raja et al., Nature Rev. Drug Discov., 2003, 2, 943-944). We have carried out a systematic high field NMR study of daptomycin and its binding to calcium ions which is essential for antibiotic activity. In this first report, we demonstrate the sequence-specific resonance assignment of daptomycin under resolved NMR measurement conditions. In addition to this, we have determined the 3D structure of apo-daptomycin and demonstrated a 1 : 1 stoichiometry on the binding to calcium ions. We have also demonstrated that the binding of calcium ions does not result in major conformational changes, but does induce aggregation. This may be an important factor in the mode of action of daptomycin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15227539     DOI: 10.1039/b402722a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  27 in total

1.  Inactivation of the lipopeptide antibiotic daptomycin by hydrolytic mechanisms.

Authors:  Vanessa M D'Costa; Tariq A Mukhtar; Tejal Patel; Kalinka Koteva; Nicholas Waglechner; Donald W Hughes; Gerard D Wright; Gianfranco De Pascale
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

2.  Development of Tyrocidine A analogues with improved antibacterial activity.

Authors:  Michael A Marques; Diane M Citron; Clay C Wang
Journal:  Bioorg Med Chem       Date:  2007-08-11       Impact factor: 3.641

3.  Isolation and structure elucidation of lipopeptide antibiotic taromycin B from the activated taromycin biosynthetic gene cluster.

Authors:  Kirk A Reynolds; Hanna Luhavaya; Jie Li; Samira Dahesh; Victor Nizet; Kazuya Yamanaka; Bradley S Moore
Journal:  J Antibiot (Tokyo)       Date:  2017-11-29       Impact factor: 2.649

4.  Molecular State of the Membrane-Active Antibiotic Daptomycin.

Authors:  Ming-Tao Lee; Wei-Chin Hung; Meng-Hsuan Hsieh; Hsiung Chen; Yu-Yung Chang; Huey W Huang
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

5.  Crystallomycin revisited after 60 years: aspartocins B and C.

Authors:  Anton P Tyurin; Vera A Alferova; Alexander S Paramonov; Maxim V Shuvalov; Irina A Malanicheva; Natalia E Grammatikova; Pavel N Solyev; Shaowei Liu; Chenghang Sun; Igor A Prokhorenko; Tatyana A Efimenko; Larisa P Terekhova; Olga V Efremenkova; Zakhar O Shenkarev; Vladimir A Korshun
Journal:  Medchemcomm       Date:  2018-02-27       Impact factor: 3.597

6.  Isolation of a Paenibacillus sp. strain and structural elucidation of its broad-spectrum lipopeptide antibiotic.

Authors:  Yaoqi Guo; En Huang; Chunhua Yuan; Liwen Zhang; Ahmed E Yousef
Journal:  Appl Environ Microbiol       Date:  2012-02-24       Impact factor: 4.792

7.  Daptomycin-Phosphatidylglycerol Domains in Lipid Membranes.

Authors:  Mark A Kreutzberger; Antje Pokorny; Paulo F Almeida
Journal:  Langmuir       Date:  2017-11-13       Impact factor: 3.882

Review 8.  Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery.

Authors:  Lars Robbel; Mohamed A Marahiel
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

9.  Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.

Authors:  Dominique Dugourd; Haiyan Yang; Melissa Elliott; Raymond Siu; Jacob J Clement; Suzana K Straus; Robert E W Hancock; Evelina Rubinchik
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

Review 10.  In Silico Discovery of Novel Ligands for Antimicrobial Lipopeptides for Computer-Aided Drug Design.

Authors:  Satya Eswari Jujjavarapu; Swasti Dhagat
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.